Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8468 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.845 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8359 |
Intermediate Similarity |
NPD1357 |
Approved |
0.8358 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8306 |
Intermediate Similarity |
NPD228 |
Approved |
0.8145 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8145 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8045 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7972 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7958 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7908 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7785 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7769 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7763 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7763 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7754 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD37 |
Approved |
0.7681 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7681 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7638 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7606 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7569 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7519 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1091 |
Approved |
0.75 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7376 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7375 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7357 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7344 |
Intermediate Similarity |
NPD968 |
Approved |
0.7343 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7305 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7266 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7266 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD6895 |
Approved |
0.726 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.726 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.723 |
Intermediate Similarity |
NPD5763 |
Approved |
0.723 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7183 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7177 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7177 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7172 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7111 |
Intermediate Similarity |
NPD709 |
Approved |
0.7111 |
Intermediate Similarity |
NPD6387 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7103 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7097 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7092 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7092 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD1182 |
Approved |
0.7078 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD52 |
Approved |
0.7078 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7071 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD1840 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7042 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7023 |
Intermediate Similarity |
NPD290 |
Approved |
0.7023 |
Intermediate Similarity |
NPD1358 |
Approved |
0.702 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD1138 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7013 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD3092 |
Approved |
0.6986 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD2801 |
Approved |
0.6974 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6972 |
Remote Similarity |
NPD6696 |
Suspended |
0.6972 |
Remote Similarity |
NPD2922 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.6957 |
Remote Similarity |
NPD3091 |
Approved |
0.6957 |
Remote Similarity |
NPD5604 |
Discontinued |
0.6957 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD5958 |
Discontinued |
0.695 |
Remote Similarity |
NPD1608 |
Approved |
0.6949 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD3134 |
Approved |
0.6944 |
Remote Similarity |
NPD5736 |
Approved |
0.694 |
Remote Similarity |
NPD1137 |
Approved |
0.694 |
Remote Similarity |
NPD1139 |
Approved |
0.6939 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD2438 |
Suspended |
0.6933 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6933 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6933 |
Remote Similarity |
NPD6032 |
Approved |
0.6923 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD7119 |
Phase 2 |
0.6909 |
Remote Similarity |
NPD2489 |
Approved |
0.6909 |
Remote Similarity |
NPD27 |
Approved |
0.6906 |
Remote Similarity |
NPD1651 |
Approved |
0.6903
|
Remote Similarity |
NPD4739 |
Approved |